Time to abandon routine urine analysis prior to Bacillus Calmette–Guérin administration in asymptomatic patients
BCG instillation with ABU is safe, and the results do not support routine screening of asymptomatic patients for bacteriuria prior to intravesical BCG immunotherapy.
Authors
- Olli Kesti
- Otto Ettala (ORCID: https://orcid.org/0000-0003-1011-4602)
- Antti Nummi (ORCID: https://orcid.org/0000-0002-4461-3373)
- Antti J. Kaipia (ORCID: https://orcid.org/0000-0003-0800-9723)
- Mikael Högerman (ORCID: https://orcid.org/0000-0002-4287-9231)
- Riikka Järvinen (ORCID: https://orcid.org/0000-0001-6182-9793)
- Pertti Nurminen (ORCID: https://orcid.org/0000-0001-9364-9754)
- Jukka Sairanen
- Peter J. Boström (ORCID: https://orcid.org/0000-0003-3647-0015)
Institutions
- University of Helsinki (FI)
- Helsinki University Hospital (FI)
- Turku University Hospital (FI)
- Tampere University Hospital (FI)
- Tampere University (FI)
Publication Details
- Journal
- BJUI Compass
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/bco2.70117
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Helsingin Yliopisto
- Turun Yliopistollinen Keskussairaala